Adeniyi Oyebade Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Graduate Student
grad_student
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Adeniyi Oyebade's research investigates the development and application of nanomedicines for therapeutic purposes. His work includes studies on doxorubicin-based ionic nanomedicines for combined chemo-phototherapy of cancer, exploring the role of endocytosis pathways and organelle trafficking in their effectiveness. Oyebade has also examined targeted delivery strategies for cancer treatment, such as using epidermal growth factor receptors to deliver rapamycin in pancreatic cancer cells to inhibit proliferation and induce apoptosis. Additionally, his research encompasses the use of antibiotics coupled with photothermal therapy for enhanced bacterial killing. Oyebade also contributes to studies on microplastics, their toxicity, and detection methods, as well as the properties of oil from underutilized citrus seeds and carbon-based anode materials for metal-ion batteries. He has collaborated with researchers from the University of Arkansas at Little Rock on multiple publications.
Metrics
- h-index: 3
- Publications: 8
- Citations: 45
Selected Publications
-
Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions (2025)
-
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
-
Comparative Study of the Physicochemical Properties of Oil from Underutilized Seeds of Citrus Paradisi, Citrus Lemon and Citrus Sinensis (2025)
-
IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
-
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
-
Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods (2024)
-
Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
-
Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria (2023)
Collaboration Network
Top Collaborators
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Showing 5 of 7 shared publications
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Showing 5 of 6 shared publications
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Antibiotics Coupled with Photothermal Therapy for the Enhanced Killing of Bacteria
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Microplastics: Challenges, toxicity, spectroscopic and real-time detection methods
Similar Researchers
Based on overlapping research topics